Studies how vision tests perform in people with retinal diseases
Observes adults with retinal degeneration to see how vision tests work.
Plain-language title generated from the registry record
Registry title: Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration
Key facts
- Where
- Irvine, United StatesSee the site
Where in United States
- Vision Research and Assessment InstituteIrvine, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Ray Therapeutics, Inc.
- Trial code
- NCT06375239
- Record updated
- 8 January 2025
- Original description
The Vision Research and Assessment Institute (VRAI) was established with the purpose of serving as a testing facility for efficacy endpoints for patients with Low Vision.Read full original descriptionShow less
Observational, Non-Interventional Study to Determine the Operational Feasibility and Measurement Properties of Endpoints in Patients with Retinal Degeneration
The Vision Research and Assessment Institute (VRAI) was established with the purpose of serving as a testing facility for efficacy endpoints for patients with Low Vision.
The mission of the VRAI is to enable the highest quality, standardized efficacy testing of patients with visual impairment.
The VRAI facilitates the development and refinement of existing endpoints specifically for testing patients with Low Vision.
Inclusion: Diagnosis of bilateral retinitis pigmentosa, choroideremia, Stargardt macular dystrophy, geographic atrophy from age-related macular degeneration, X-linked retinoschisis or other retinal dystrophies confirmed from previous eye examination records; Best-corrected visual acuity between 20/70 and HM in at least one eye as tested with clinic-based visual acuity method; Reasonably fluent in English.
Exclusion: Cognitive impairment, memory loss or dementia sufficient in severity to preclude informed consent or in the opinion of the investigator would prevent satisfactory completion of some or all of the testing; Any circumstance that in the opinion of the investigator, would interfere with participation in, or compliance with the study protocol; Current pregnancy as reported by patient.